Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
Journal of Pharmacology and Toxicology
  Year: 2008 | Volume: 3 | Issue: 2 | Page No.: 93-101
DOI: 10.3923/jpt.2008.93.101
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Molecular Modelling Analysis of the Metabolism of Zolpidem

Fazlul Huq

Abstract:
Zolpidem (ZP) is a new orally active sleep inducer belonging to the class of compounds known as imidazopyridine. Molecular modelling analyses based on molecular mechanics, semi-empirical (PM3) and DFT (at B3LYP/6-31G* level) calculations show that parent drug and all its metabolites have moderately large LUMO-HOMO energy differences so that none is expected to be highly labile kinetically. The molecular surface of ZP is found to abound in electron-deficient regions so that it can react with cellular nucleophiles such as glutathione and nucleobases in DNA, thus inducing cellular toxicity and causing DNA damage respectively. However, because of kinetic inertness, the rates of such adverse reaction may be low unless speeded up enzymatically. Increased incidence of nausea and vomiting associated with higher doses of ZP may be due to the parent drug rather than any of its metabolites.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

Fazlul Huq , 2008. Molecular Modelling Analysis of the Metabolism of Zolpidem. Journal of Pharmacology and Toxicology, 3: 93-101.

DOI: 10.3923/jpt.2008.93.101

URL: https://scialert.net/abstract/?doi=jpt.2008.93.101

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 

Curve Bottom